Beranda › Kanker (semua jenis) › South Dakota › Sioux Falls
Uji klinis Kanker (semua jenis) di Sioux Falls, SD
13 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Sioux Falls (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Menerima pesertaFase 1/2
- Sanford Children's Hospital ( Site 4015), Sioux Falls
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- Sanford Cancer Center Oncology Clinic and Pharmacy, Sioux Falls
Connect for Cancer Prevention Study (Connect)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Sanford Health, Sioux Falls
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Menerima pesertaFase 1/2
- Sanford Children's Hospital ( Site 3015), Sioux Falls
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Menerima pesertaFase 3
- Research Site, Sioux Falls
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- Sanford Sioux Falls, Sioux Falls
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Menerima pesertaFase 2
- Sanford Cancer Center Oncology Clinic ( Site 0038), Sioux Falls
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Sanford Cancer Center Oncology Clinic, Sioux Falls
- Avera Cancer Institute, Sioux Falls
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Menerima pesertaFase 3
- Avera Medical Group Gynecologic Oncology Sioux Falls, Sioux Falls
- Texas Oncology, P.A. - Tyler, Sioux Falls
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- Sanford Clinical Research, Sioux Falls
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Menerima pesertaStudi observasional
- Avera Cancer Institute, Sioux Falls
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Sanford Cancer Center Oncology Clinic, Sioux Falls
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY109 studi
- Boston, MA85 studi
- Los Angeles, CA74 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Washington, DC58 studi
- Durham, NC58 studi
- Chicago, IL51 studi
- Atlanta, GA49 studi
- Seattle, WA49 studi
- Arlington, VA48 studi
Studi lain di Sioux Falls
- Kanker Paru Non-Sel Kecil19 studi
- Kanker Payudara18 studi
- Kanker Ovarium16 studi
- Kanker Paru14 studi
- Kanker Endometrium11 studi
- Kanker Metastatik10 studi
- Kanker Kolorektal9 studi
- Karsinoma Sel Skuamosa Kepala dan Leher9 studi
- Gagal Jantung7 studi
- Kanker Kolon7 studi
- Kanker Payudara Triple-Negatif7 studi
- Kanker Prostat7 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.